379 Shares in Intuitive Surgical, Inc. $ISRG Acquired by Westover Capital Advisors LLC

Westover Capital Advisors LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 379 shares of the medical equipment provider’s stock, valued at approximately $206,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in shares of Intuitive Surgical by 1.4% in the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after buying an additional 453,335 shares in the last quarter. Geode Capital Management LLC grew its stake in Intuitive Surgical by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after acquiring an additional 109,904 shares in the last quarter. Invesco Ltd. raised its holdings in Intuitive Surgical by 1.7% in the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after acquiring an additional 71,794 shares during the last quarter. Northern Trust Corp raised its holdings in Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after acquiring an additional 11,988 shares during the last quarter. Finally, Wellington Management Group LLP lifted its stake in Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after purchasing an additional 457,080 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.0%

ISRG stock opened at $546.77 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The stock has a market cap of $196.00 billion, a price-to-earnings ratio of 72.32, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62. The business has a fifty day moving average of $485.63 and a two-hundred day moving average of $503.34.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s revenue was up 22.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.84 EPS. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity at Intuitive Surgical

In other news, EVP Myriam Curet sold 7,562 shares of the company’s stock in a transaction that occurred on Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total value of $4,147,227.66. Following the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $193,595.79. This represents a 95.54% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of the stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the transaction, the chief executive officer directly owned 234,256 shares of the company’s stock, valued at $128,266,872.80. The trade was a 9.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 116,164 shares of company stock valued at $61,916,172 over the last quarter. 0.70% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the company. BTIG Research upped their price target on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Royal Bank Of Canada set a $625.00 target price on Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, October 31st. Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 24th. Finally, Rothschild & Co Redburn upped their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $608.92.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.